Jude Samulski News Today

See which leaders are on the move across the pharma, biotech and medical marketing industries.

Gene therapy legend R. Jude Samulski, Ph.D., co-founder and chief scientific officer of Asklepios BioPharmaceutical (AskBio) since the company was established in 2001, is leaving the CSO job but remaining on the company board.AskBio announced that Mansuo Shannon, Ph.D., becomes CSO effective today. Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, where she also served as CSO.

Preliminary study of messenger RNA therapy against propionic acidaemia shows it is safe, but doubts remain about its usefulness

The North Carolina Biotechnology Center is turning 40 years old. NCBiotech was founded in 1984, the first organization of its kind, as a catalyst for technology-based economic development in life sciences.  As we celebrate this important milestone, it is important to take stock of where we have been, how far we have come as a life sciences hub, and where we are headed next. 

GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic cardiomyopathy 

Jaguar Gene Therapy – which arrived in North Carolina in 2021 – is creating a new company to manage its chemistry, manufacturing and controls (CMC) capabilities.

A recent article published earlier this month in Frontier in Cellular and Infection Microbiology, recognized R. Jude Samulski, Ph.D., as the most cited and co-cited expert for AAV gene therapy advancements. Here are the details.

A recent article, “Bibliometric analysis of global research trends in adeno-associated virus vector for gene therapy (1991-2022),” published earlier this month in Frontier in Cellular and Infection Microbiology, recognized R. Jude Samulski, Ph.D., as the most cited and co-cited expert for AAV gene therapy advancements.

Conner Curran, 12, has Duchenne muscular dystrophy and will participate in a trial to potentially receive the gene therapy that has improved his quality of life

Four oral presentations and seven poster presentations will share insights into AskBios adeno-associated virus research, development and pre-clin...